Sharareh Gholamin
Affiliations: | 2012-2017 | Neurosurgery | Stanford University School of Medicine, Palo Alto, CA, United States |
Website:
https://www.parkerici.org/person/sharareh-gholamin-phd/Google:
"Sharareh Gholamin"Bio:
https://www.its.caltech.edu/~heathgrp/grads.html
https://www.researchgate.net/profile/Sharareh_Gholamin
Mean distance: (not calculated yet)
Parents
Sign in to add mentor| James Richard Heath | grad student | 2016- | Caltech (Chemistry Tree) |
| Samuel H. Cheshier | post-doc | 2012-2017 | Stanford Medical School |
| Siddhartha S. Mitra | post-doc | 2012-2017 | Stanford Medical School |
| Irving L. Weissman | post-doc | 2012-2017 | Stanford Medical School (FlyTree) |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Gholamin S, Youssef OA, Rafat M, et al. (2019) Irradiation or temozolomide chemotherapy enhances anti-CD47 treatment of glioblastoma. Innate Immunity. 1753425919876690 |
| Hutter G, Theruvath J, Graef CM, et al. (2019) Microglia are effector cells of CD47-SIRPα antiphagocytic axis disruption against glioblastoma. Proceedings of the National Academy of Sciences of the United States of America |
| Kahn SA, Wang X, Nitta RT, et al. (2018) Publisher Correction: Notch1 regulates the initiation of metastasis and self-renewal of Group 3 medulloblastoma. Nature Communications. 9: 4651 |
| Kahn SA, Wang X, Nitta RT, et al. (2018) Notch1 regulates the initiation of metastasis and self-renewal of Group 3 medulloblastoma. Nature Communications. 9: 4121 |
| Purzner T, Purzner J, Buckstaff T, et al. (2018) Developmental phosphoproteomics identifies the kinase CK2 as a driver of Hedgehog signaling and a therapeutic target in medulloblastoma. Science Signaling. 11 |
| Dos Santos Cavalcanti A, Meohas W, Ribeiro GO, et al. (2017) Patient-derived osteosarcoma cells are resistant to methotrexate. Plos One. 12: e0184891 |
| Gholamin S, Mitra SS, Feroze AH, et al. (2017) Disrupting the CD47-SIRPα anti-phagocytic axis by a humanized anti-CD47 antibody is an efficacious treatment for malignant pediatric brain tumors. Science Translational Medicine. 9 |
| Chang J, Mancuso MR, Maier C, et al. (2017) Gpr124 is essential for blood-brain barrier integrity in central nervous system disease. Nature Medicine |
| Gholamin S, Esparza R, Cheshier S, et al. (2017) TRTH-32. COMBINATION IMMUNOTHERAPY TO ACTIVATE THE INNATE IMMUNE MICROENVIRONMENT AGAINST PEDIATRIC BRAIN TUMORS Neuro-Oncology. 19: iv58-iv59 |
| Gholamin S, Kahn S, Esparza R, et al. (2017) IMMU-18. HUMANIZED ANTI-CD47 ANTIBODY COMBINED WITH AN AGONIST ANTI-CD40 ANTIBODY IS AN EFFECTIVE TREATMENT FOR DIPG XENOGRAFTS WITH CRANIOSPINAL DISSEMINATION Neuro-Oncology. 19: iv31-iv31 |